ALGN
Price
$173.66
Change
+$4.58 (+2.71%)
Updated
Aug 7 closing price
Capitalization
12.34B
81 days until earnings call
Intraday BUY SELL Signals
TMDX
Price
$83.89
Change
+$3.68 (+4.59%)
Updated
Aug 7 closing price
Capitalization
2.91B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALGN vs TMDX

ALGN vs TMDX Comparison Chart in %
View a ticker or compare two or three
VS
ALGN vs. TMDX commentary
Aug 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a StrongBuy and TMDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2026
Stock price -- (ALGN: $173.66 vs. TMDX: $83.89)
Brand notoriety: ALGN: Notable vs. TMDX: Not notable
ALGN represents the Pharmaceuticals: Other, while TMDX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ALGN: 64% vs. TMDX: 49%
Market capitalization -- ALGN: $12.34B vs. TMDX: $2.91B
ALGN [@Pharmaceuticals: Other] is valued at $12.34B. TMDX’s [@Medical/Nursing Services] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $133.83B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $186.55B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.39B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 1 FA rating(s) are green whileTMDX’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 1 green, 4 red.
  • TMDX’s FA Score: 1 green, 4 red.
According to our system of comparison, ALGN is a better buy in the long-term than TMDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 4 TA indicator(s) are bullish while TMDX’s TA Score has 6 bullish TA indicator(s).

  • ALGN’s TA Score: 4 bullish, 5 bearish.
  • TMDX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TMDX is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а +2.66% price change this week, while TMDX (@Medical/Nursing Services) price change was +9.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.34%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +2.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +5.89%. For the same industry, the average monthly price growth was -1.59%, and the average quarterly price growth was -8.72%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 28, 2026.

TMDX is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+4.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+5.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($12.3B) has a higher market cap than TMDX($2.91B). ALGN has higher P/E ratio than TMDX: ALGN (30.17) vs TMDX (21.73). ALGN YTD gains are higher at: 8.281 vs. TMDX (-34.065). ALGN has higher annual earnings (EBITDA): 877M vs. TMDX (140M). ALGN has more cash in the bank: 1.06B vs. TMDX (462M). ALGN has less debt than TMDX: ALGN (116M) vs TMDX (863M). ALGN has higher revenues than TMDX: ALGN (4.1B) vs TMDX (636M).
ALGNTMDXALGN / TMDX
Capitalization12.3B2.91B423%
EBITDA877M140M626%
Gain YTD8.281-34.065-24%
P/E Ratio30.1721.73139%
Revenue4.1B636M644%
Total Cash1.06B462M229%
Total Debt116M863M13%
FUNDAMENTALS RATINGS
ALGN vs TMDX: Fundamental Ratings
ALGN
TMDX
OUTLOOK RATING
1..100
2227
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
6923
PRICE GROWTH RATING
1..100
5958
P/E GROWTH RATING
1..100
2697
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (62) in the Medical Specialties industry is in the same range as TMDX (74). This means that ALGN’s stock grew similarly to TMDX’s over the last 12 months.

TMDX's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as ALGN (100). This means that TMDX’s stock grew similarly to ALGN’s over the last 12 months.

TMDX's SMR Rating (23) in the Medical Specialties industry is somewhat better than the same rating for ALGN (69). This means that TMDX’s stock grew somewhat faster than ALGN’s over the last 12 months.

TMDX's Price Growth Rating (58) in the Medical Specialties industry is in the same range as ALGN (59). This means that TMDX’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's P/E Growth Rating (26) in the Medical Specialties industry is significantly better than the same rating for TMDX (97). This means that ALGN’s stock grew significantly faster than TMDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNTMDX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signal:
Gain/Loss:
TMDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PBNV31.46N/A
N/A
PGIM S&P 500 Buffer 20 ETF - Nov
SCOW23.33N/A
N/A
Pacer S&P SmCp 600 Qul FCF Aristcrts ETF
GPRF49.49-0.05
-0.10%
Goldman Sachs Acs US Pref Stk &HySecETF
USCL86.62-0.16
-0.19%
iShares Climate Conscious &TrnMSCIUSAETF
IBTO23.78-0.08
-0.32%
iShares iBonds Dec 2033 Term Trsy ETF